Reported about 10 hours ago
Janux Therapeutics, Inc. (JANX) is highlighted as a leading stock choice of unknown billionaire Phill Gross due to its substantial upside potential of nearly 190%. The firm, known for its innovative cancer immunotherapies, has maintained a strong financial position, with over $1 billion in cash reserves, enabling ongoing research and development. Despite reporting losses in the recent fiscal year as it expands its clinical programs, its investment potential remains significant, especially after Adage Capital Management greatly increased its holdings in the company.
Source: YAHOO